• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION 2.5/35; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION 2.5/35; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 419144
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Myocardial Infarction (1969); Thrombosis/Thrombus (4440)
Event Date 02/22/2023
Event Type  Injury  
Manufacturer Narrative
Combination product: yes.
 
Event Description
15 days after initial treatment with placement of two orsiro mission drug eluting stents in a mildly calcified lesion (95 percent stenosis degree) in the mid rca.The patient was transferred to the hospital with an acute inferior myocardial infarction.During the emergency cag, a complete thrombus occlusion was noticed on the distal part of the rca.After repeated aspiration and balloon dilatations, timi 3 flow was obtained.An aortic balloon pumping (iabp) was inserted to secure coronary artery blood flow.Two days later the iabp was removed.Patient was discharged home.The second stent is reported separately.
 
Manufacturer Narrative
Combination product: yes.The affected orsiro mission stent systems were not returned to biotronik and could therefore not be subjected to a technical investigation.Images of the case such as angiographies or other relevant clinical information could not be obtained.Review of the product release documentation confirmed that the devices were manufactured according to specifications and fulfilled all the requirements of in-process and final inspection.Based on the reviewed documentation no device deficiency or manufacturing-related root cause could be identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO MISSION 2.5/35
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
Manufacturer Contact
6024 jean road
lake oswego, OR 97035
8772459800
MDR Report Key16645705
MDR Text Key312344687
Report Number1028232-2023-01600
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier07640130442047
UDI-Public(01)07640130442047(17)2405
Combination Product (y/n)Y
Reporter Country CodeCH
PMA/PMN Number
P170030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility,Company Representative,Distributor
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 05/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/30/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number419144
Device Catalogue NumberSEE MODEL NO.
Device Lot Number05220120
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/03/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/16/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-